HealthQuill Sage Therapeutics
An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies to halt the trial.
Drugs Health Pharma

Biogen, Sage halt tremor trial after ‘disappointing’ oral drug results

An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.

Read More
The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after childbirth or during the later stages of pregnancy.
Drugs Health Pharma

FDA clears first oral drug to treat postpartum depression or ‘baby blues’

HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after.

Read More
X